CONCERT PHARMACEUTICALS INC (CNCE) Stock News

NASDAQ:CNCE - Nasdaq - US2060221056 - Common Stock - Currency: USD

8.37 +0.01 (+0.12%)

After market: 8.4 +0.03 (+0.36%)

Technical Analysis

Fundamental Analysis

Analyst Ratings

Earnings Estimates

CNCE Latest News, Press Relases and Analysis

All

Press Releases

3 years ago - By: Seeking Alpha

Concert retains breakthrough tag for hair loss therapy despite rival entry (NASDAQ:CNCE)

3 years ago - By: Concert Pharmaceuticals, Inc.

Concert Pharmaceuticals Maintains Deuruxolitinib Breakthrough Therapy Designation from FDA for the Treatment of Alopecia Areata

3 years ago - By: Halper Sadeh LLC

CNCE Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Concert Pharmaceuticals, Inc. Is Fair to Shareholders

3 years ago - By: Benzinga - Mentions: SRDX TNXP BLCM BYSI ...

News Image

12 Health Care Stocks Moving In Thursday's Intraday Session

3 years ago - By: Benzinga

India-Based Sun Pharma Scoops Up Concert Pharmaceuticals For $576M Plus Milestones

3 years ago - By: Sun Pharmaceutical Industries Ltd.

Sun Pharma entend acquérir Concert Pharmaceuticals pour faire progresser le traitement potentiel de l'alopécie areata

3 years ago - By: Sun Pharmaceutical Industries Ltd.

Sun Pharma adquire Concert Pharmaceuticals, avançando no tratamento potencial para a Alopecia Areata

3 years ago - By: Sun Pharmaceutical Industries Ltd.

Sun Pharma adquiere Concert Pharmaceuticals para avanzar en el tratamiento de la alopecia areata

3 years ago - By: Sun Pharmaceutical Industries Ltd.

Sun Pharma erwirbt Concert Pharmaceuticals und treibt damit die Behandlung von Alopecia areata voran

3 years ago - By: The Motley Fool

Why Concert Pharmaceuticals Stock Rocketed Higher This Week

3 years ago - By: Kahn Swick & Foti, LLC

CONCERT PHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Concert Pharmaceuticals, Inc. - CNCE

3 years ago - By: Weiss Law

SHAREHOLDER ALERT: Weiss Law Investigates Concert Pharmaceuticals, Inc.

3 years ago - By: Seeking Alpha - Mentions: RIVN SRDX EDU

Hot Stocks: CNCE takeover deal; SRDX plunges; EDU reaches 52-week high; RIVN sets new low

3 years ago - By: Ademi LLP

Shareholder Alert: Ademi LLP investigates whether Concert Pharmaceuticals, Inc. has obtained a Fair Price in its transaction with Sun Pharma

3 years ago - By: Halper Sadeh LLC

CNCE Stock Alert: Halper Sadeh LLC is Investigating Whether the Sale of Concert Pharmaceuticals, Inc. Is Fair to Shareholders

3 years ago - By: Sun Pharmaceutical Industries Ltd.

Sun Pharma to Acquire Concert Pharmaceuticals, Advancing the Potential Treatment of Alopecia Areata

3 years ago - By: Concert Pharmaceuticals

Sun Pharma to Acquire Concert Pharmaceuticals, Advancing the Potential Treatment of Alopecia Areata

3 years ago - By: Concert Pharmaceuticals, Inc.

Concert Pharmaceuticals Announces Presentation of Deuruxolitinib THRIVE-AA1 Phase 3 Study Results in Alopecia Areata During World Congress for Hair Research

3 years ago - By: Concert Pharmaceuticals

Concert Pharmaceuticals to Participate in Fireside Chat at the Jefferies London Healthcare Conference